GRI Bio (GRI) News Today 0.54 -0.11 (-17.23%) (As of 11:19 AM ET) Add Compare Share Share Today's Range0.49▼0.5850-Day Range0.65▼1.7152-Week Range0.49▼36.90Volume776,104 shsAverage Volume142,831 shsMarket Capitalization$1.75 millionP/E RatioN/ADividend YieldN/APrice TargetN/A HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineGRI Bio Says FDA Clears IND For GRI-0621 For Treatment Of IPF; Stock Up 19%markets.businessinsider.com - November 27 at 10:18 PMGRI Bio stock slides 9% amid FDA clearance for testing of IPF drugmsn.com - November 27 at 5:18 PMGRI Bio Inc GRImorningstar.com - November 24 at 11:15 PMGRI Bio (NASDAQ:GRI) Trading 2.1% Higher americanbankingnews.com - November 18 at 3:42 AMGRI Bio, Inc.: GRI Bio (NASDAQ: GRI) Reports Third Quarter 2023 Financial Results and Provides Corporate Updatefinanznachrichten.de - November 15 at 3:10 PMGRI Bio reports Q3 resultsmsn.com - November 15 at 3:10 PMLawsuit alleges plan to open a marijuana store in former Rainforest Cafe is illegalmsn.com - November 6 at 8:26 PMPot shop company files suit to blunt planned dispensary at former Rainforest Cafe, limit proximity of minority-owned storeschicago.suntimes.com - October 31 at 5:31 PMGRI Bio Partners With NIHR Respiratory TRC To Advance NKT Regulation Technology - Quick Factsmarkets.businessinsider.com - October 17 at 3:08 PMGRI Bio (NASDAQ: GRI) to Participate in the Virtual Investor Ask the CEO Conferencefinance.yahoo.com - October 11 at 9:44 AMGRI Bio, Inc.: September Is Pulmonary Fibrosis Awareness Month: Here's What One Company Is Doing To Develop A Treatment For This Deadly Diseasefinanznachrichten.de - September 29 at 10:28 AMThinking about buying stock in SeqLL, GRI Bio, Earlyworks Co, TradeUP Acquisition, or Safety Shot?benzinga.com - September 18 at 3:55 PMDisease With Market Estimated At $3.9 Billion Lacks Cure – Will This Company Be The First To Find One?benzinga.com - September 15 at 4:11 PMElon Musk blocked Ukrainian attack on Russia's Black Sea fleet, says new biographymsn.com - September 8 at 3:29 PMIPF Has A 0% Survival Rate Without Lung Transplant And A Median Survival Time Of 2-5 Years From Diagnosis - Could GRI-0621 Be The Solution?finance.yahoo.com - September 1 at 11:12 AMGRI Bio Engages B2i Digital to Deploy Cutting-Edge Engagement Campaignfinance.yahoo.com - August 29 at 12:54 PMGRI Bio Is Bringing Hope To Patients With Idiopathic Pulmonary Fibrosis And Lupusfinance.yahoo.com - August 25 at 1:46 PMThinking about buying stock in MicroCloud Hologram, AgileThought, GRI Bio, Profire Energy, or Foot Locker?benzinga.com - August 24 at 3:40 PMGRI Bio Shares Slide to 52-Week Low Amid Sale of Adair Asset >GRImarketwatch.com - August 23 at 6:45 PMGRI Bio Enters into Asset Purchase Agreement with Aardvark Therapeutics, Inc. for the Sale of Legacy Asset, ADAIRfinance.yahoo.com - August 23 at 6:45 PMGRI Bio (NASDAQ: GRI) Reports Second Quarter 2023 Financial Results and Provides Corporate Updatefinance.yahoo.com - August 14 at 4:24 PMGRI Bio Head Talks Macro Picture For Biotech At Benzinga Webinarbenzinga.com - August 8 at 8:02 AMGRI Bio Presents Encouraging Preclinical Data Indicating Oral Administration of GRI-0803 Inhibited Lupus Nephritis and Significantly Improved Overall Survival in Animal Modelsfinance.yahoo.com - August 8 at 8:02 AMGRI Bio (NASDAQ: GRI) to Present at Benzinga’s Virtual Biotech Conferencefinance.yahoo.com - August 3 at 1:22 PMJTC Team, LLC: JTC Team to Host Two Virtual Investor Spotlight Events on Thursday, July 27thfinanznachrichten.de - July 27 at 8:19 PMJTC Team to Host Two Virtual Investor Spotlight Events on Thursday, July 27thfinance.yahoo.com - July 26 at 4:49 PMGRI Bio (NASDAQ: GRI) to Present at the Virtual Investor – The GRI Opportunity Spotlight Eventfinance.yahoo.com - July 24 at 1:51 PMBio-Rad Publishes Corporate Sustainability Report for 2022finance.yahoo.com - July 10 at 9:34 AMGRI Bio, Inc. (NASDAQ: GRI) to Participate in the Virtual Investor Summer Spotlight Seriesfinance.yahoo.com - July 5 at 1:44 PMGRI Bio (NASDAQ: GRI) Bolsters Patent Portfoliofinance.yahoo.com - June 27 at 11:53 AMGRI Bio Incmoney.usnews.com - June 23 at 11:35 PMGRI Bio (NASDAQ: GRI) to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and Hosted by M-Vestfinance.yahoo.com - June 15 at 3:12 PMGRI Bio, Inc.: GRI Bio (NASDAQ: GRI) Announces Corporate Rebranding and Launch of New Websitefinanznachrichten.de - June 13 at 3:38 PMGRI Bio (NASDAQ: GRI) Announces Corporate Rebranding and Launch of New Websitefinance.yahoo.com - June 13 at 9:59 AMGRI Bio (NASDAQ: GRI) Provides Business Outlook and Highlights Upcoming Milestones for Innovative Pipeline of NKT Cell Modulatorsfinance.yahoo.com - May 22 at 9:56 AMGRI Bio (NASDAQ: GRI) to Present at the Virtual Investor New to the Street Eventfinance.yahoo.com - May 4 at 4:44 PMmarketbeat.com - April 25 at 11:30 AMmarketbeat.com - April 24 at 9:40 AM Get GRI Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GRI and its competitors with MarketBeat's FREE daily newsletter. Email Address GRI Media Mentions By Week GRI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GRI News Sentiment▼0.510.82▲Average Medical News Sentiment GRI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GRI Articles This Week▼41▲GRI Articles Average Week Get GRI Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GRI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ARDS News CLVR News ENVB News BDRX News FWBI News ARTL News HILS News THAR News QLGN News SXTP News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat Originals This page (NASDAQ:GRI) was last updated on 11/28/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GRI Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.